Evaluation of Measles Immunity among Children Aged 9 to 59 Months at Selected Health Facilities in Kwale, Narok and Lamu Counties of Kenya

Show simple item record

dc.contributor.author Kanga, Ali Juma
dc.date.accessioned 2021-09-01T08:02:07Z
dc.date.available 2021-09-01T08:02:07Z
dc.date.issued 2021-09-01
dc.identifier.uri http://localhost/xmlui/handle/123456789/5625
dc.description Master of Science in Medical Laboratory Sciences (Clinical and Public Health Virology) en_US
dc.description.abstract Measles burden has been on the decline globally since 1980 due to universal use of measles vaccine; with outbreaks reported in Africa, parts of Europe and Asia in 2008. Population immunity assessment is key to determining progress towards elimination of measles as advised by World Health Organisation (WHO). Kenya relies on incidence reports, since there is scanty information on prevailing measles immunity and risk awareness status. The aim of this study was to evaluate measles immunity among children aged 9 to 59 months at selected health facilities in Kwale, Narok and Lamu Counties of Kenya. This was a hospital-based cross-sectional descriptive study in which 453 children were studied. A structured questionnaire was used, blood was collected and dried blood spots (DBS) prepared. Detection of measles IgG antibodies was done by ELISA. Plaque reduction neutralization test (PRNT) was used to confirm serology equivocal results. Results were correlated with actual vaccination coverage, demographic and vaccination history data. The number and percentages of positive and negative sera were found, Chi-square used to compare proportions and a 95% confidence interval used to describe limits of percentages. Individuals found to have Measles IgG titres comparable to 200mIU/ ml, were considered protected. The study recruited 233 (51.4%) male and 220 (48.6%) female children. Most of the children 408/453 {(90.1%) 95%CI; 81.8% to 98.4%)} were vaccinated, while only 11/453 {(2.4%) 95% CI; 2.2% to 2.6%)} were not vaccinated. Among the study group, 346/453(76.4%) children had vaccination cards, 107(23.6%) did not (P < 0.001). Overall, 396/453 {(87.4%) 95% CI; 84.4% to 90.5%)} children had protective antibody titres, while 57/453 {(12.6%) 95% CI; 9.5% to 15.7%)} did not (P = 0.000). The proportion of vaccinated children with protective antibody titre was 362/408 {(88.7%) 95% CI; 85.8% to 91.6%}. The general population immunity against measles disease in the children under study was low. At 87.4%, this indicates that the herd immunity in the study group falls below the WHO recommended minimum levels of 93-95%. A country wide assessment of measles population immunity and measles vaccine awareness is required in Kenya. This shall help in identifying the most vulnerable regions and step up strategies to build up herd immunity in these zones, a good step to measles elimination in Kenya. en_US
dc.description.sponsorship Dr. Juliette R. Ongus, PhD JKUAT, Kenya Serah N. Kaggia (MBChB, Mmed Path) JKUAT, Kenya Dr. Raphael Mwamtsi Lwembe, PhD KEMRI, Kenya en_US
dc.language.iso en en_US
dc.publisher JKUAT-COHES en_US
dc.subject Narok and Lamu Counties of Kenya en_US
dc.subject Health Facilities en_US
dc.subject Children Aged 9 to 59 Months en_US
dc.subject Measles Immunity en_US
dc.title Evaluation of Measles Immunity among Children Aged 9 to 59 Months at Selected Health Facilities in Kwale, Narok and Lamu Counties of Kenya en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

  • College of Health Sciences (COHES) [773]
    Medical Laboratory; Agriculture & environmental Biotecthology; Biochemistry; Molecular Medicine, Applied Epidemiology; Medicinal PhytochemistryPublic Health;

Show simple item record

Search DSpace


Browse

My Account